{"pmid":32454808,"pmcid":"PMC7241574","title":"To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19.","text":["To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19.","A rapid systematic review was carried out to evaluate the current evidence related to the presence of SARS-CoV-2 in breast milk from pregnant women with COVID-19. Eight studies analyzing the presence of SARS-CoV-2 RNA in the breast milk of 24 pregnant women with COVID-19 during the third trimester of pregnancy were found. All patients had fever and/or symptoms of acute respiratory illness and chest computed tomography images indicative of COVID-19 pneumonia. Most pregnant women had cesarean delivery (91.7%) and two neonates had low birthweight (< 2 500 g). Biological samples collected immediately after birth from upper respiratory tract (throat or nasopharyngeal) of neonates and placental tissues showed negative results for the presence SARS-CoV-2 by RT-PCR test. No breast milk samples were positive for SARS-CoV-2 and, to date, there is no evidence on the presence of SARS-CoV-2 in breast milk of pregnant women with COVID-19. However, data are still limited and breastfeeding of women with COVID-19 remains a controversial issue. There are no restrictions on the use of milk from a human breast milk bank.","Rev Panam Salud Publica","Martins-Filho, Paulo Ricardo","Santos, Victor Santana","Santos, Hudson P Jr","32454808"],"abstract":["A rapid systematic review was carried out to evaluate the current evidence related to the presence of SARS-CoV-2 in breast milk from pregnant women with COVID-19. Eight studies analyzing the presence of SARS-CoV-2 RNA in the breast milk of 24 pregnant women with COVID-19 during the third trimester of pregnancy were found. All patients had fever and/or symptoms of acute respiratory illness and chest computed tomography images indicative of COVID-19 pneumonia. Most pregnant women had cesarean delivery (91.7%) and two neonates had low birthweight (< 2 500 g). Biological samples collected immediately after birth from upper respiratory tract (throat or nasopharyngeal) of neonates and placental tissues showed negative results for the presence SARS-CoV-2 by RT-PCR test. No breast milk samples were positive for SARS-CoV-2 and, to date, there is no evidence on the presence of SARS-CoV-2 in breast milk of pregnant women with COVID-19. However, data are still limited and breastfeeding of women with COVID-19 remains a controversial issue. There are no restrictions on the use of milk from a human breast milk bank."],"journal":"Rev Panam Salud Publica","authors":["Martins-Filho, Paulo Ricardo","Santos, Victor Santana","Santos, Hudson P Jr"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454808","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.26633/RPSP.2020.59","keywords":["coronavirus infection","sars virus","breast feeding","pandemics","pneumonia, viral","virus diseases"],"topics":["Diagnosis"],"weight":1,"_version_":1667983494513426432,"score":9.490897,"similar":[{"pmid":32369656,"title":"Coronavirus disease 2019 among pregnant Chinese women: Case series data on the safety of vaginal birth and breastfeeding.","text":["Coronavirus disease 2019 among pregnant Chinese women: Case series data on the safety of vaginal birth and breastfeeding.","OBJECTIVE: To assess whether vaginal secretions and breast milk of COVID-19 patients contain SARS-CoV-2 virus. DESIGN: Single center cohort study. SETTING: Renmin Hospital of Wuhan University, Wuhan, Hubei province, China. POPULATION OR SAMPLE: We studied 13 COVID-19 infected pregnant women diagnosed between January 31 and March 9, 2020. METHODS: We collected clinical data, vaginal secretions and stool specimens, breast milk from COVID-19 infected women during different stages of pregnancy and neonatal throat, anal swabs. MAIN OUTCOME(S) AND MEASURE(S): We assessed viral presence in different biosamples. RESULTS: Of the 13 women with COVID-19, 5 were in their first trimester, 3 in their second trimester, and 5 in their third trimester. Of the 5 women during their third trimester who gave birth, all delivered live newborns. Among these 5 deliveries, the primary adverse perinatal outcomes included premature delivery (n = 2) and neonatal pneumonia (n = 2). One of 9 stool samples was positive; and all 13 vaginal secretion samples, and 5 throat swabs and 4 anal swabs collected from newborns were negative for the novel coronavirus. However, 1 of 3 samples of breast milk was positive by viral nucleic acid testing. CONCLUSIONS: In this case series of 13 pregnant women with COVID-19, we observed negative viral test results in vaginal secretion specimens, suggesting that a vaginal delivery may be a safe delivery option. However, additional research is urgently needed to examine breast milk and the potential risk for viral contamination.","BJOG","Wu, Yanting","Liu, Chen","Dong, Lan","Zhang, Chenjie","Chen, Yang","Liu, Jun","Zhang, Chen","Duan, Chenchi","Zhang, Hanqiu","Mol, Ben W","Dennis, Cindy-Lee","Yin, Tailang","Yang, Jing","Huang, Hefeng","32369656"],"abstract":["OBJECTIVE: To assess whether vaginal secretions and breast milk of COVID-19 patients contain SARS-CoV-2 virus. DESIGN: Single center cohort study. SETTING: Renmin Hospital of Wuhan University, Wuhan, Hubei province, China. POPULATION OR SAMPLE: We studied 13 COVID-19 infected pregnant women diagnosed between January 31 and March 9, 2020. METHODS: We collected clinical data, vaginal secretions and stool specimens, breast milk from COVID-19 infected women during different stages of pregnancy and neonatal throat, anal swabs. MAIN OUTCOME(S) AND MEASURE(S): We assessed viral presence in different biosamples. RESULTS: Of the 13 women with COVID-19, 5 were in their first trimester, 3 in their second trimester, and 5 in their third trimester. Of the 5 women during their third trimester who gave birth, all delivered live newborns. Among these 5 deliveries, the primary adverse perinatal outcomes included premature delivery (n = 2) and neonatal pneumonia (n = 2). One of 9 stool samples was positive; and all 13 vaginal secretion samples, and 5 throat swabs and 4 anal swabs collected from newborns were negative for the novel coronavirus. However, 1 of 3 samples of breast milk was positive by viral nucleic acid testing. CONCLUSIONS: In this case series of 13 pregnant women with COVID-19, we observed negative viral test results in vaginal secretion specimens, suggesting that a vaginal delivery may be a safe delivery option. However, additional research is urgently needed to examine breast milk and the potential risk for viral contamination."],"journal":"BJOG","authors":["Wu, Yanting","Liu, Chen","Dong, Lan","Zhang, Chenjie","Chen, Yang","Liu, Jun","Zhang, Chen","Duan, Chenchi","Zhang, Hanqiu","Mol, Ben W","Dennis, Cindy-Lee","Yin, Tailang","Yang, Jing","Huang, Hefeng"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369656","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/1471-0528.16276","keywords":["covid-19","breast milk","vaginal secretions"],"locations":["Wuhan","Hubei","China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1666138496159449088,"score":588.63696},{"pmid":32452195,"title":"COVID-19 and pregnancy - where are we now? A review.","text":["COVID-19 and pregnancy - where are we now? A review.","The new acute respiratory disease severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is highly contagious. It has caused many deaths, despite a relatively low general case fatality rate (CFR). The most common early manifestations of infection are fever, cough, fatigue and myalgia. The diagnosis is based on the exposure history, clinical manifestation, laboratory test results, chest computed tomography (CT) findings and a positive reverse transcription-polymerase chain reaction (RT-PCR) result for coronavirus disease 2019 (COVID-19). The effect of SARS-CoV-2 on pregnancy is not already clear. There is no evidence that pregnant women are more susceptible than the general population. In the third trimester, COVID-19 can cause premature rupture of membranes, premature labour and fetal distress. There are no data on complications of SARS-CoV-2 infection before the third trimester. COVID-19 infection is an indication for delivery if necessary to improve maternal oxygenation. Decision on delivery mode should be individualised. Vertical transmission of coronavirus from the pregnant woman to the fetus has not been proven. As the virus is absent in breast milk, the experts encourage breastfeeding for neonatal acquisition of protective antibodies.","J Perinat Med","Rajewska, Aleksandra","Mikolajek-Bedner, Wioletta","Lebdowicz-Knul, Joanna","Sokolowska, Malgorzata","Kwiatkowski, Sebastian","Torbe, Andrzej","32452195"],"abstract":["The new acute respiratory disease severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is highly contagious. It has caused many deaths, despite a relatively low general case fatality rate (CFR). The most common early manifestations of infection are fever, cough, fatigue and myalgia. The diagnosis is based on the exposure history, clinical manifestation, laboratory test results, chest computed tomography (CT) findings and a positive reverse transcription-polymerase chain reaction (RT-PCR) result for coronavirus disease 2019 (COVID-19). The effect of SARS-CoV-2 on pregnancy is not already clear. There is no evidence that pregnant women are more susceptible than the general population. In the third trimester, COVID-19 can cause premature rupture of membranes, premature labour and fetal distress. There are no data on complications of SARS-CoV-2 infection before the third trimester. COVID-19 infection is an indication for delivery if necessary to improve maternal oxygenation. Decision on delivery mode should be individualised. Vertical transmission of coronavirus from the pregnant woman to the fetus has not been proven. As the virus is absent in breast milk, the experts encourage breastfeeding for neonatal acquisition of protective antibodies."],"journal":"J Perinat Med","authors":["Rajewska, Aleksandra","Mikolajek-Bedner, Wioletta","Lebdowicz-Knul, Joanna","Sokolowska, Malgorzata","Kwiatkowski, Sebastian","Torbe, Andrzej"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452195","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1515/jpm-2020-0132","keywords":["covid-19","coronavirus","delivery","pregnancy"],"locations":["membranes"],"topics":["Transmission"],"weight":1,"_version_":1667983494535446528,"score":437.67465},{"pmid":32376317,"pmcid":"PMC7196550","title":"Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19).","text":["Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19).","COVID-19 can severely affect pregnant women and the issue of vertical transmission of sars-cov-2 has also emerged. Sars-cov-2 could be recovered by real-time (RT) PCR from nasal and throat swabs, sputum and feces of symptomatic patients including neonates but not from vaginal swabs, amniotic fluid, placenta, cord blood, neonatal blood or breast milk. Viremia was present in 1% of symptomatic adults. We identified 12 articles published between February 10(th) and April 4(th) 2020 reporting on 68 deliveries and 71 neonates with maternal infection in the third trimester of pregnancy. Perinatal exposure, including mode of delivery and time interval from delivery to the diagnosis of neonatal infection are crucial in differentiating congenital from perinatal infection. Neonatal infection is usually asymptomatic. Neonatal infection was diagnosed within 48 hours of life in 4 cases. Detection rates of real-time PCR and the interpretation of IgM and IgG antibodies levels in cord and neonatal blood are discussed in relation with the immaturity of the fetal and neonatal immune system.","Am J Obstet Gynecol","A, Amouroux","T, Attie-Bitach","J, Martinovic","M, Leruez-Ville","Y, Ville","32376317"],"abstract":["COVID-19 can severely affect pregnant women and the issue of vertical transmission of sars-cov-2 has also emerged. Sars-cov-2 could be recovered by real-time (RT) PCR from nasal and throat swabs, sputum and feces of symptomatic patients including neonates but not from vaginal swabs, amniotic fluid, placenta, cord blood, neonatal blood or breast milk. Viremia was present in 1% of symptomatic adults. We identified 12 articles published between February 10(th) and April 4(th) 2020 reporting on 68 deliveries and 71 neonates with maternal infection in the third trimester of pregnancy. Perinatal exposure, including mode of delivery and time interval from delivery to the diagnosis of neonatal infection are crucial in differentiating congenital from perinatal infection. Neonatal infection is usually asymptomatic. Neonatal infection was diagnosed within 48 hours of life in 4 cases. Detection rates of real-time PCR and the interpretation of IgM and IgG antibodies levels in cord and neonatal blood are discussed in relation with the immaturity of the fetal and neonatal immune system."],"journal":"Am J Obstet Gynecol","authors":["A, Amouroux","T, Attie-Bitach","J, Martinovic","M, Leruez-Ville","Y, Ville"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376317","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ajog.2020.04.039","keywords":["igg","igm","rt-pcr","fetus","placenta","sars-cov-2"],"locations":["placenta","Viremia"],"topics":["Transmission"],"weight":1,"_version_":1666262687548440577,"score":392.4012},{"pmid":32458823,"title":"[Coronavirus Covid-19 infection and breastfeeding: an exploratory review].","text":["[Coronavirus Covid-19 infection and breastfeeding: an exploratory review].","BACKGROUND: The new coronavirus disease is an infectious disease caused by the SARS-Cov-2 virus, considered by the World Health Organization (WHO) an international public health emergency that may have negative consequences during breastfeeding. The objective of this work is to investigate the action plan on breastfeeding in postpartum women with SARS-CoV-2 and her newborn. METHODS: A literature search has been conducted through the Medline, Web of Science, Scopus, BVS, and Cuiden databases. The methodological quality of the articles has been assessed using the \"Grading of Recommendations Assessment, Development and Evaluation\" (GRADE). This study has not been registered in PROSPERO. RESULTS: A total of 14 documents have been found, of which 9 are observational empirical studies. Most of the studies were conducted in China, Italy, the USA, and Australia. A total of 114 mothers infected with coronavirus with their respective newborns have been assessed. The analyzed investigations state that it is best for the newborn to be breastfed; given that mother's milk samples were analyzed, detecting the presence of antibodies of the coronavirus in them, being a protective factor against infection. CONCLUSIONS: Breastfeeding in postpartum women with SARS-CoV-2 is highly recommended for the newborn, if the health of the mother and newborn allow it. When direct breastfeeding is favoured, the appropriate respiratory hygiene measures always have to be considered. Whether the mother's health does not permit direct breastfeeding, her breast milk should be previously extracted and kept unpasteurized. To secure the newborn feeding, milk banks are also an appropriate option.","Rev Esp Salud Publica","Fernandez-Carrasco, Francisco Javier","Vazquez-Lara, Juana Maria","Gonzalez-Mey, Urbano","Gomez-Salgado, Juan","Parron-Carreno, Tesifon","Rodriguez-Diaz, Luciano","32458823"],"abstract":["BACKGROUND: The new coronavirus disease is an infectious disease caused by the SARS-Cov-2 virus, considered by the World Health Organization (WHO) an international public health emergency that may have negative consequences during breastfeeding. The objective of this work is to investigate the action plan on breastfeeding in postpartum women with SARS-CoV-2 and her newborn. METHODS: A literature search has been conducted through the Medline, Web of Science, Scopus, BVS, and Cuiden databases. The methodological quality of the articles has been assessed using the \"Grading of Recommendations Assessment, Development and Evaluation\" (GRADE). This study has not been registered in PROSPERO. RESULTS: A total of 14 documents have been found, of which 9 are observational empirical studies. Most of the studies were conducted in China, Italy, the USA, and Australia. A total of 114 mothers infected with coronavirus with their respective newborns have been assessed. The analyzed investigations state that it is best for the newborn to be breastfed; given that mother's milk samples were analyzed, detecting the presence of antibodies of the coronavirus in them, being a protective factor against infection. CONCLUSIONS: Breastfeeding in postpartum women with SARS-CoV-2 is highly recommended for the newborn, if the health of the mother and newborn allow it. When direct breastfeeding is favoured, the appropriate respiratory hygiene measures always have to be considered. Whether the mother's health does not permit direct breastfeeding, her breast milk should be previously extracted and kept unpasteurized. To secure the newborn feeding, milk banks are also an appropriate option."],"journal":"Rev Esp Salud Publica","authors":["Fernandez-Carrasco, Francisco Javier","Vazquez-Lara, Juana Maria","Gonzalez-Mey, Urbano","Gomez-Salgado, Juan","Parron-Carreno, Tesifon","Rodriguez-Diaz, Luciano"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458823","source":"PubMed","week":"202022|May 25 - May 31","keywords":["covid-19","maternal breastfeeding","neonate","new-born","pregnancy","scoping review","spain"],"locations":["Scopus","China","Italy","USA","Australia"],"countries":["Australia","China","United States","Italy"],"countries_codes":["AUS|Australia","CHN|China","USA|United States","ITA|Italy"],"topics":["Mechanism","Prevention"],"weight":1,"_version_":1667967698988957696,"score":387.6558},{"pmid":32454807,"pmcid":"PMC7241573","title":"COVID-19 and newborn health: systematic review.","text":["COVID-19 and newborn health: systematic review.","Objective: To describe perinatal and neonatal outcomes in newborns exposed to SARS-CoV-2. Methods: A systematic review was conducted by searching PubMed Central, LILACS, and Google Scholar using the keywords 'covid ' AND 'newborn' OR 'child' OR 'infant,' on 18 March 2020, and again on 17 April 2020. One researcher conducted the search and extracted data on demographics, maternal outcomes, diagnostic tests, imaging, and neonatal outcomes. Results: Of 256 publications identified, 20 met inclusion criteria and comprised neonatal outcome data for 222 newborns whose mothers were suspected or confirmed to be SARS-CoV-2 positive perinatally (17 studies) or of newborns referred to hospital with infection/pneumonia (3 studies). Most (12 studies) were case-series reports; all were from China, except three (Australia, Iran, and Spain). Of the 222 newborns, 13 were reported as positive for SARS-CoV-2; most of the studies reported no or mild symptoms and no adverse perinatal outcomes. Two papers among those from newborns who tested positive reported moderate or severe clinical characteristics. Five studies using data on umbilical cord blood, placenta, and/or amniotic fluid reported no positive results. Nine studies reported radiographic imaging, including 5 with images of pneumonia, increased lung marking, thickened texture, or high-density nodular shadow. Minor, non-specific changes in biochemical variables were reported. Studies that tested breast milk reported negative SARS-CoV-2 results. Conclusions: Given the paucity of studies at this time, vertical transmission cannot be confirmed or denied. Current literature does not support abstaining from breastfeeding nor separating mothers and newborns. Further evidence and data collection networks, particularly in the Americas, are needed for establishing definitive guidelines and recommendations.","Rev Panam Salud Publica","Duran, Pablo","Berman, Stephen","Niermeyer, Susan","Jaenisch, Thomas","Forster, Thais","Gomez Ponce de Leon, Rodolfo","De Mucio, Bremen","Serruya, Suzanne","32454807"],"abstract":["Objective: To describe perinatal and neonatal outcomes in newborns exposed to SARS-CoV-2. Methods: A systematic review was conducted by searching PubMed Central, LILACS, and Google Scholar using the keywords 'covid ' AND 'newborn' OR 'child' OR 'infant,' on 18 March 2020, and again on 17 April 2020. One researcher conducted the search and extracted data on demographics, maternal outcomes, diagnostic tests, imaging, and neonatal outcomes. Results: Of 256 publications identified, 20 met inclusion criteria and comprised neonatal outcome data for 222 newborns whose mothers were suspected or confirmed to be SARS-CoV-2 positive perinatally (17 studies) or of newborns referred to hospital with infection/pneumonia (3 studies). Most (12 studies) were case-series reports; all were from China, except three (Australia, Iran, and Spain). Of the 222 newborns, 13 were reported as positive for SARS-CoV-2; most of the studies reported no or mild symptoms and no adverse perinatal outcomes. Two papers among those from newborns who tested positive reported moderate or severe clinical characteristics. Five studies using data on umbilical cord blood, placenta, and/or amniotic fluid reported no positive results. Nine studies reported radiographic imaging, including 5 with images of pneumonia, increased lung marking, thickened texture, or high-density nodular shadow. Minor, non-specific changes in biochemical variables were reported. Studies that tested breast milk reported negative SARS-CoV-2 results. Conclusions: Given the paucity of studies at this time, vertical transmission cannot be confirmed or denied. Current literature does not support abstaining from breastfeeding nor separating mothers and newborns. Further evidence and data collection networks, particularly in the Americas, are needed for establishing definitive guidelines and recommendations."],"journal":"Rev Panam Salud Publica","authors":["Duran, Pablo","Berman, Stephen","Niermeyer, Susan","Jaenisch, Thomas","Forster, Thais","Gomez Ponce de Leon, Rodolfo","De Mucio, Bremen","Serruya, Suzanne"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454807","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.26633/RPSP.2020.54","keywords":["coronavirus infection","sars virus","congenital, hereditary, and neonatal diseases and abnormalities","infectious disease transmission, vertical","pandemics","virus diseases"],"locations":["China","Australia","Iran","Spain","placenta"],"countries":["China","Iran, Islamic Republic of","Spain","Australia"],"countries_codes":["CHN|China","IRN|Iran, Islamic Republic of","ESP|Spain","AUS|Australia"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1667881798407815168,"score":384.39523}]}